nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—APEX1—neck—esophageal cancer	0.0459	0.135	CbGeAlD
Lucanthone—APEX1—Resolution of AP sites via the single-nucleotide replacement pathway—XRCC1—esophageal cancer	0.041	0.0632	CbGpPWpGaD
Lucanthone—APEX1—Displacement of DNA glycosylase by APE1—SMUG1—esophageal cancer	0.0336	0.0518	CbGpPWpGaD
Lucanthone—APEX1—epithelium—esophageal cancer	0.0312	0.0918	CbGeAlD
Lucanthone—APEX1—Base-free sugar-phosphate removal via the single-nucleotide replacement pathway—SMUG1—esophageal cancer	0.0309	0.0476	CbGpPWpGaD
Lucanthone—APEX1—bronchus—esophageal cancer	0.0307	0.0905	CbGeAlD
Lucanthone—APEX1—smooth muscle tissue—esophageal cancer	0.0301	0.0885	CbGeAlD
Lucanthone—APEX1—Base Excision Repair—XRCC1—esophageal cancer	0.0284	0.0438	CbGpPWpGaD
Lucanthone—APEX1—trachea—esophageal cancer	0.0276	0.0812	CbGeAlD
Lucanthone—APEX1—Resolution of AP sites via the single-nucleotide replacement pathway—SMUG1—esophageal cancer	0.0267	0.0411	CbGpPWpGaD
Lucanthone—APEX1—digestive system—esophageal cancer	0.0237	0.0699	CbGeAlD
Lucanthone—TOP1—bronchus—esophageal cancer	0.0215	0.0633	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—TNFRSF10A—esophageal cancer	0.0214	0.033	CbGpPWpGaD
Lucanthone—TOP1—smooth muscle tissue—esophageal cancer	0.021	0.0619	CbGeAlD
Lucanthone—APEX1—Removal of DNA patch containing abasic residue—SMUG1—esophageal cancer	0.0202	0.0311	CbGpPWpGaD
Lucanthone—APEX1—lung—esophageal cancer	0.0198	0.0584	CbGeAlD
Lucanthone—TOP1—trachea—esophageal cancer	0.0193	0.0568	CbGeAlD
Lucanthone—APEX1—Base Excision Repair—SMUG1—esophageal cancer	0.0185	0.0285	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—MMP14—esophageal cancer	0.0166	0.0255	CbGpPWpGaD
Lucanthone—TOP2A—bronchus—esophageal cancer	0.0153	0.045	CbGeAlD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—XIAP—esophageal cancer	0.0148	0.0229	CbGpPWpGaD
Lucanthone—TOP1—lung—esophageal cancer	0.0139	0.0408	CbGeAlD
Lucanthone—APEX1—lymph node—esophageal cancer	0.0136	0.0399	CbGeAlD
Lucanthone—TOP1—Circadian rythm related genes—CRTC1—esophageal cancer	0.0103	0.0159	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—KRT14—esophageal cancer	0.0103	0.0159	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PDE4D—esophageal cancer	0.01	0.0154	CbGpPWpGaD
Lucanthone—TOP2A—lung—esophageal cancer	0.00988	0.0291	CbGeAlD
Lucanthone—TOP1—lymph node—esophageal cancer	0.00949	0.0279	CbGeAlD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00934	0.0144	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—FKBP1A—esophageal cancer	0.00928	0.0143	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—HIST1H2BM—esophageal cancer	0.00883	0.0136	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BAX—esophageal cancer	0.00876	0.0135	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RUNX1—esophageal cancer	0.0084	0.0129	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—KDR—esophageal cancer	0.0074	0.0114	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—HIST1H2BM—esophageal cancer	0.00736	0.0113	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.00725	0.0112	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—XRCC1—esophageal cancer	0.00682	0.0105	CbGpPWpGaD
Lucanthone—TOP2A—lymph node—esophageal cancer	0.00675	0.0199	CbGeAlD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—CREBBP—esophageal cancer	0.00632	0.00974	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—CASP8—esophageal cancer	0.00622	0.00959	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—LGALS3—esophageal cancer	0.00607	0.00936	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—PSME1—esophageal cancer	0.0058	0.00894	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—PSME2—esophageal cancer	0.0058	0.00894	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—SFN—esophageal cancer	0.00573	0.00883	CbGpPWpGaD
Lucanthone—Amiodarone—CYP2A6—esophageal cancer	0.00558	0.495	CrCbGaD
Lucanthone—APEX1—DNA Replication—PSME1—esophageal cancer	0.00544	0.00839	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—PSME2—esophageal cancer	0.00544	0.00839	CbGpPWpGaD
Lucanthone—TOP1—Caspase Cascade in Apoptosis—BCL2—esophageal cancer	0.00534	0.00823	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CXCL2—esophageal cancer	0.00527	0.00812	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00493	0.0076	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—ANXA1—esophageal cancer	0.0049	0.00755	CbGpPWpGaD
Lucanthone—APEX1—S Phase—PSME1—esophageal cancer	0.00476	0.00734	CbGpPWpGaD
Lucanthone—APEX1—S Phase—PSME2—esophageal cancer	0.00476	0.00734	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00451	0.00695	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GHRL—esophageal cancer	0.00449	0.00692	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—SMUG1—esophageal cancer	0.00444	0.00684	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—esophageal cancer	0.00441	0.0068	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—AJUBA—esophageal cancer	0.00436	0.00672	CbGpPWpGaD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—EP300—esophageal cancer	0.00431	0.00664	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00429	0.00661	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—AJUBA—esophageal cancer	0.0039	0.006	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RB1—esophageal cancer	0.00371	0.00571	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—NOTCH1—esophageal cancer	0.00366	0.00565	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00364	0.0056	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MLH3—esophageal cancer	0.00352	0.00543	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.00352	0.00543	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.00352	0.00543	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.00333	0.00513	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CRTC1—esophageal cancer	0.00322	0.00496	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00292	0.0045	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—esophageal cancer	0.00275	0.00423	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TLR4—esophageal cancer	0.00274	0.00422	CbGpPWpGaD
Lucanthone—Flurazepam—CYP2A6—esophageal cancer	0.00264	0.234	CrCbGaD
Lucanthone—APEX1—Spinal Cord Injury—NOS2—esophageal cancer	0.0026	0.00401	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.00258	0.00397	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—esophageal cancer	0.00258	0.00397	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—NOS2—esophageal cancer	0.00252	0.00388	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—esophageal cancer	0.00249	0.00384	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00236	0.00364	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.00235	0.00363	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—esophageal cancer	0.00233	0.00359	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.00227	0.00349	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—esophageal cancer	0.00225	0.00347	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—MYC—esophageal cancer	0.00221	0.0034	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.00213	0.00328	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.00209	0.00322	CbGpPWpGaD
Lucanthone—Amiodarone—ABCB1—esophageal cancer	0.00208	0.184	CrCbGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—PSME1—esophageal cancer	0.00204	0.00315	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—PSME2—esophageal cancer	0.00204	0.00315	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.00203	0.00313	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—AJUBA—esophageal cancer	0.00202	0.00311	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—esophageal cancer	0.00198	0.00305	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—CDKN1A—esophageal cancer	0.00197	0.00304	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.00197	0.00304	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.00193	0.00297	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—esophageal cancer	0.00191	0.00295	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—PIK3CA—esophageal cancer	0.00187	0.00289	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—MYC—esophageal cancer	0.00187	0.00288	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—HIST1H2BM—esophageal cancer	0.00187	0.00288	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—CDKN1A—esophageal cancer	0.00185	0.00285	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.00184	0.00284	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—esophageal cancer	0.00183	0.00282	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—AJUBA—esophageal cancer	0.0018	0.00278	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.00174	0.00268	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CCND1—esophageal cancer	0.00173	0.00266	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.00168	0.0026	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CCND1—esophageal cancer	0.00167	0.00258	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MAD2L1—esophageal cancer	0.00165	0.00254	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MLH3—esophageal cancer	0.00163	0.00251	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.00162	0.0025	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.00162	0.0025	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDKN1A—esophageal cancer	0.00162	0.00249	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.0016	0.00247	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.00154	0.00237	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EP300—esophageal cancer	0.00154	0.00237	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—esophageal cancer	0.00153	0.00237	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.00147	0.00227	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PSME2—esophageal cancer	0.00145	0.00223	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—PSME1—esophageal cancer	0.00145	0.00223	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00141	0.00217	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GHRL—esophageal cancer	0.0014	0.00216	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.0014	0.00215	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MYC—esophageal cancer	0.00139	0.00214	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.00137	0.00212	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.00137	0.00211	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—esophageal cancer	0.00136	0.00209	CbGpPWpGaD
Lucanthone—APEX1—S Phase—MYC—esophageal cancer	0.00134	0.00207	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00134	0.00207	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BUB1B—esophageal cancer	0.00132	0.00203	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CHEK2—esophageal cancer	0.00125	0.00193	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00119	0.00183	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.00115	0.00177	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—esophageal cancer	0.00114	0.00176	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00114	0.00175	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—esophageal cancer	0.0011	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.0011	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.0011	0.0017	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.00104	0.0016	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.00102	0.00157	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000987	0.00152	CbGpPWpGaD
Lucanthone—Flurazepam—ABCB1—esophageal cancer	0.000984	0.0872	CrCbGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—esophageal cancer	0.000967	0.00149	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—HIST1H2BM—esophageal cancer	0.000966	0.00149	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—HIST1H2BM—esophageal cancer	0.000864	0.00133	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MAD2L1—esophageal cancer	0.000853	0.00131	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN2A—esophageal cancer	0.00085	0.00131	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000818	0.00126	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—NOS2—esophageal cancer	0.000786	0.00121	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000767	0.00118	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MAD2L1—esophageal cancer	0.000763	0.00118	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PSME1—esophageal cancer	0.000749	0.00115	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—PSME2—esophageal cancer	0.000749	0.00115	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000738	0.00114	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000735	0.00113	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CCND1—esophageal cancer	0.000718	0.00111	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDKN1A—esophageal cancer	0.000695	0.00107	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—esophageal cancer	0.000686	0.00106	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—BUB1B—esophageal cancer	0.000682	0.00105	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000674	0.00104	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000672	0.00104	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PSME2—esophageal cancer	0.00067	0.00103	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—PSME1—esophageal cancer	0.00067	0.00103	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000634	0.000977	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000616	0.000949	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BUB1B—esophageal cancer	0.00061	0.00094	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN2A—esophageal cancer	0.000603	0.000929	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000602	0.000928	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CHEK2—esophageal cancer	0.00058	0.000894	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—MYC—esophageal cancer	0.000576	0.000888	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000569	0.000877	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000551	0.000849	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000544	0.000838	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000526	0.000811	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000524	0.000808	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CCND1—esophageal cancer	0.000509	0.000785	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000501	0.000772	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDKN1A—esophageal cancer	0.000492	0.000759	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EP300—esophageal cancer	0.000481	0.000741	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—EP300—esophageal cancer	0.000469	0.000722	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000457	0.000704	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000436	0.000672	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000427	0.000658	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MYC—esophageal cancer	0.000408	0.000629	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.00037	0.000571	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000358	0.000552	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000355	0.000546	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—esophageal cancer	0.000344	0.00053	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—esophageal cancer	0.000335	0.000517	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—esophageal cancer	0.000317	0.000489	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.000312	0.00048	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN2A—esophageal cancer	0.000279	0.000429	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.000263	0.000406	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000255	0.000393	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000242	0.000374	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CCND1—esophageal cancer	0.000235	0.000363	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDKN1A—esophageal cancer	0.000228	0.000351	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—EP300—esophageal cancer	0.000217	0.000334	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000211	0.000326	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MYC—esophageal cancer	0.000189	0.000291	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—esophageal cancer	0.000155	0.000239	CbGpPWpGaD
